ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2025

[Olaparib for high-risk biochemically recurrent prostate cancer following prostatectomy].

Katharina Hintelmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.